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The classical view of delayed hypersensitivity
assigns to the circulating lymphocytes a unique
role in the eliciting reaction. Key to the concept
are two types of experiments: 1) the successful
passive transfer of delayed hypersensitivity with
white blood cells (and not sera), and 2) the dis-
appearance of already established delayed hyper-
sensitivity during periods of lymphopenia
induced by specific antisera or by whole body
irradiation. Particularly as a result of studies in
lymphopenic animals has it been suggested that a
circulating mononuclear cell, probably the small
lymphocyte, is the primary reactor in the various
types of delayed hypersensitivity reactions (1).
In the course of another investigation (2) we
noted, contrary to expectation, that contact
sensitized guinea pigs deprived of circulating
white blood cells by a cancer chemotherapeutic
drug gave normal allergic eliciting reactions. In
this paper we present a re-examination of this
phenomenon based on gross and histological
examinations of contact dermatitis sites in guinea
pigs made panleukopenic.
METHODS
Stock non-inbred albino guinea pigs weiglung
350 to 500 grams received standard vivarium care.
Tetracycline (Polyotic®) was added to their
drinking water while they were on leukopenogenic
drug; this antibiotic prophylaxis markedly de-
creased mortality.
Sensitization
Four weeks prior to ptoducing leukopenia we
sensitized groups of 15 animals with. 0,1 cc. of 1
per cent dinitrochlorobenzene (DNCB) in pro-
pylene glycol. In our laboratory this technic
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results in sensitization of 95 per cent or more of
treated animals.
Injection sites consisted of either the shaved
sacral area or the dorsal foot pads. The pressure
obtainable with a metal cartridge syringe
(Tubex®) facilitates intradermal injection.
Challenge
After shaving with a laboratory clipper we
evenly pipetted 0.05 cc. of 0.1 per cent DNCB
solution in absolute alcohol onto a premarked
circle 2.9 cm. in diameter. A hair dryer hastened
the evaporation of the alcohol (2). A single param-
eter of gross reaction was evaluated, viz cry-
thema, since this has proven in our hands to be
the most sensitive, reliable and objective measure
of allergic contact sensitivity in guinea pigs.
Readings were at 24 hours. Erythema was graded
as follows:
0—none
1+—less than 25 per cent of circle erythem-
123
atous
2+—more than 25 per cent but less than SO
per cent erytbematous
3+—SO per cent to 100 per cent of circle
erythematous
4+—ulceration
A croton oil (primary irritant) challenge was
performed in some, but not all, animals; this
consisted of 0.025 cc. of 0.1 per cent croton oil
pipetted onto a shaved, premarked circle 2.9 cm.
in diameter.
Induction of Leulcopenia
In our first experiments the animals received
cyclophosphamide (Cytoxan®) intraperitone-
ally 10 mg. daily. Starting on the 10th day white
blood counts were done every other day until the
animal had less than 1,000 white blood cells per
cubic millimeter. This dosage schedule produced
a mortality of from 30 to 50 per cent before the
completion of an experiment.
In later experiments the animals received 20
mg. of the drug every other day, rather than 10
mg. daily. This produced an equal degree of
leukopenia but far less mortality.
Controls
Groups of 6 sensitized and 6 non-sensitized
animals did not receive cyclophosphoramide so
as to serve as positive (sensitized, non-leukopenic)
and negative controls.
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TABLE I
Clinical
Method of Treatment Wht BI d$unt°°
Appearance,
Amount of
Erythema(0 tn 4+)
Histologic Appearance
DNCB—Control
1 10,550 3 + Acanthosis, spongiosis, exocytosis, and
round cell infiltrate
moderate
2 9,100 2 + Same as above
3 11,450 2 + Same as above
Leukopenie
1 650 2 + Epidermis normal, perivaseular round cell
mild
infiltrate
2 175 2 + Epidermis normal, perivaseular round cell
moderate
infiltrate
3 425 3 + Epidermis normal, perivaseular round cell
mild
infiltrate
4 0 2 + Epidermis normal, perivascular round cell
normal
infiltrate
5 0 2 + Epidermis normal, perivascular round cell
normal
infiltrate
6 800 2 + Epidermis normal, perivascular round cell
moderate
infiltrate
7 275 3 + Epidermis normal, perivascular round cell
mild
infiltrate
White Blood Counts
We utilized a direct cbamber count. When the
total white blood count fell below 1,000 per cubic
millimeter, we examined a two to four times larger
blood sample. All bleedings were from the ear.
Histopathology
After 24 hour fixation in 10 per cent neutral
formalin, the skin was embedded, cut at approxi-
mately 7 jz and stained with hematoxylin and
cosin. We recorded our observations before break-
ing the slide's code.
EESULT5
Clinical Observations
In Table I we have summarized the data of this
experiment.
The gross appearance of dermatitis (intensity
of erythema) seen following challenge of DNCB
sensitized panleukopenic animals was essentially
of the sante degree of intensity as that seen in
challenged DNCB sensitized non-leukopenic
controls (Fig. 1). As indicated in the Table, on
several occasions we were afforded the oppor-
tunity of eliciting animals essentially free of
circulating white blood cells. The dermatitis
produced was of an intensity equal to the DNCB
sensitized non-leukopenic controls.
Groups of leukopenic and non-Icukopenic
non-sensitized controls were challenged with
DNCB and ihowed no 24 hour reactions.
Severely debilitated animals with extreme
weight loss were an exception to the rule; in such
half-alive guinea pigs both specific allergic and
primary irritant reactions were diminished or
even absent.
Histopathology
Control adimals displayed the expected re-
sponse to the allergen in varying degrees of
ncanthosis, spongiosis, exocytosis and a marked
perivascular infiltrate (Figs. 2 and 3).
We observed an entirely different picture in
leukopenic animals (Fig. 4). The epidermis was
entirely normal. Serial section revealed no evi-
dence of epidermal response to injury.
The dermis appeared normal, except for the
presence of a minimal to mild perivascular round
cell infiltrate. In a few of the most severely
leukopenic animals no infiltrate was noted.
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DISCUSSION
From these observations it IS Clear that severely
leukopenic animals can and do, in fact, respond
briskly to DNCB contact dermatitis. On histo-
logic examination we observe that this occurs
with only a minimal or no round cell infiltrate and
fails to show evidence of epidermal change.
Vasodilatation would not be picked up histo-
logically; yet, it is quite obvious that vasodilata-
tion is the key and pathognomonic feature of the
clinical, macroscopic, allergic contact dermatitis
reaction to IDNCB in the guinea pig.
This data strongly suggests that the primary
change lies in the blood vessels and excludes the
circulating lymphocyte as the key end reactor.
The usual concept of the formation of circu-
lating antibody (precipitins, hemagglutinins,
etc.) states that the round cell (probably the
lymphocyte) is an antibody-making factory freely
circulating in the blood and also relatively fixed
in structures such as the lymph node and spleen.
Accordingly, passive transfer of immediate type
antibody formation can be thought of as the
transfer of capital equipment (antibody-forming
cells) (3). However, classical theory teaches a
dichotomy between immediate and delayed type
FIG. 1. DNCB contact dermatitis in a lcuko- sensitivity, whereby the sensitivity factor in
penic animal. No white blood c9lls wore noted in delayed hypersensitivity is somehow bound toa chamber count done at the time of elicitation
. .
and repeated when the photograph was taken. the circulating round cell and not delivered
Fio. 2. Histopathology of DNCB dermatitis in a control animal. Characteristics are spongiosis,
exocytosis and a marked perivascular infiltrate (H + E )< 456).
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Fio. 3. Histopathology of untreated guinea pig skin. This magnification is comparable to other
photographs (H + E X 456).
Fin. 4. Histopathology of DNCB contact dermatitis in severely leukopenic animal. Note the lack of
spongiosis and exocytosis, as well as the very minimal perivascular infiltrate (H + E X 456).
independently into the circulation—the antibody
factory and its antibody-like product never quite
separate.
We consider this hypothesis to be wrong. A
major evidence offered in its favor is that cells,
but not sera, transfer the delayed sensitivities.
However, this failure to regularly transfer delayed
hypersensitivity with sera we believe may reflect
a technical inadequacy of man, not nature. A
more crucial allegation is based on reports that
depletion of the lymphocytes by x-ray or specific
antisera in already sensitized animals results in
the specific loss of delayed type hypersensitivity.
This work would appear to firmly link the sensi-
tivity factor to the lymphocyte. However, the
contrary would also hold—and with even more
force. If lymphocyte depletion did not obliterate
already established hypersensitivity, then there
must be a cleavage between sensitivity factor and
circulatory cell, prior to the final reaction at the
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challenge site. We offer just such contrary
evidence. Cytoxan-made-leukopenic animals pro-
duce clinical allergic contact dermatitis reactions
that are grossly indistinguishable from those of
non-leukopenic animals. It should be noted that
the extent of the lymphopenia in our animals
was generally more profound than in the x-rayed
or antisera treated animals (4).
Furthermore, we have repeated the oft cited
x-ray experiments (summarized by Waksman)
(1) and, contrary to the literature, find that whole
body x-ray (300 to 500 r) has no perceptible
effect on the allergic contact dermatitis eliciting
reaction (5).
SUMMARY
1. IDNCB-sensitized guinea pigs made severely
panleukopenic (total circulating white blood
count of 0 to 800 cells per cu. mm.), when elicited
with DNCB, display the same allergic gross
dermatitis reaction as control animals.
2. Histologically, the dermatitis reveals only
minimal round cell infiltration and no evidence of
epidermal involvement. The histopathological
changes in no wise match the clinical appearance.
3. An exception to this observation is that
severely debilitated guinea pigs give weakened
skin reactions, both of the specific allergic and
non-specific primary irritant types.
4. The white blood cell is responsible for the
major epidermal injury; induced leukopenia
seemingly protects the epidermis from agents that
would otherwise produce epidermis damage.
5. We postulate that the antibody of delayed
hypersensitivity (DNCB contact dermatitis)
separates from the lymphocyte early in the proc-
ess of sensitization in a manner analogous to that
of the antibodies of immediate hypersensitivity.
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